Lysosome targeted drugs: rhodamine B modified N^N-chelating ligands for half-sandwich iridium(<scp>iii</scp>) anticancer complexes
-
- Wenli Ma
- Institute of Anticancer Agents Development and Theranostic Application
-
- Zhenzhen Tian
- Institute of Anticancer Agents Development and Theranostic Application
-
- Shumiao Zhang
- Institute of Anticancer Agents Development and Theranostic Application
-
- Xiangdong He
- Institute of Anticancer Agents Development and Theranostic Application
-
- JuanJuan Li
- Institute of Anticancer Agents Development and Theranostic Application
-
- Xiaorong Xia
- Institute of Anticancer Agents Development and Theranostic Application
-
- Xiaobing Chen
- Institute of Anticancer Agents Development and Theranostic Application
-
- Zhe Liu
- Institute of Anticancer Agents Development and Theranostic Application
説明
<p>We designed and synthesized four rhodamine-modified half-sandwich iridium complexes ([(η5-Cpx)Ir(N^N)Cl]PF6).</p>
収録刊行物
-
- Inorganic Chemistry Frontiers
-
Inorganic Chemistry Frontiers 5 (10), 2587-2597, 2018
Royal Society of Chemistry (RSC)
